OverviewChartNewsTraderScreen

Soc. Generale Knock-Out MRK/  DE000SF8RCV1  /

Frankfurt Zert./SG
07/11/2024  13:27:45 Chg.0.000 Bid14:18:29 Ask14:18:29 Underlying Strike price Expiration date Option type
2.550EUR 0.00% 2.540
Bid Size: 3,000		 2.600
Ask Size: 3,000		 Merck and Co Inc 73.8431 USD 31/12/2078 Call
TeleTrader 31/10 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 31/07 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 30/07 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 17/07 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
TeleTrader 01/07 US closes higher after data
GlobeNewswire 27/06 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 26/06 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 30/05 Monte Rosa Therapeutics Announces Leadership Team Promotions
TeleTrader 28/05 US markets turn to losses, Dow plunges 330 points
GlobeNewswire 28/05 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 23/05 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 23/05 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 16/05 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 14/05 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 08/05 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 25/04 American Kidney Fund Launches National Kidney Health Equity Media Campaign
TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 24/04 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire 18/04 The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 15/04 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 09/04 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire 05/04 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 03/04 TOMI Environmental Solutions Receives Gold Safety Award from Highwire